ACE Report Cover
No Increase In Adverse Events With Lateral Extra-Articular Tenodesis Augmentation Of ACLR
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SPORTS MEDICINE
No Increase In Adverse Events With Lateral Extra-Articular Tenodesis Augmentation Of ACLR .

No increase in adverse events with lateral extra-articular tenodesis augmentation of anterior cruciate ligament reconstruction - Results from the stability randomized trial.

J ISAKOS . 2023 Aug;8(4):246-254.

Six hundred and eighteen patients aged 14–25 years with ACL-deficient knees were randomized to receive either hamstring tendon ACL reconstruction alone (n=312) or with an additional lateral extra-articular tenodesis (LET) (n=306). The primary outcome was graft rupture. Secondary outcomes included minor medical events, minor surgical events, contralateral ACL ruptures, overall reoperation rates, pain (P4), range of motion, and patient-reported outcomes (IKDC, KOOS, ACL-QOL). Outcomes were assessed up to 24 months. Overall, the results of the study revealed a significantly lower rate of graft rupture in the ACLR + LET group compared to ACLR alone, without an increase in overall adverse events or reoperation rates. These findings suggest that adding LET to ACLR in high-risk young patients significantly reduces the risk of graft failure without increasing serious complications.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. No Increase In Adverse Events With Lateral Extra-Articular Tenodesis Augmentation Of ACLR. ACE Report. 2025;307(6):42. Available from: https://myorthoevidence.com/AceReport/Show/no-increase-in-adverse-events-with-lateral-extra-articular-tenodesis-augmentation-of-aclr

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report